GDG memberInterest
David EvansMember of the British Thoracic Society.
Member of the RCP Acute Medicine Task Force.
Wife was a Non-Executive Director of the Central Cornwall Primary Care Trust.
Mark FarringtonEmployed by the Health Protection Agency.
Provides occasional expert advice and commentary to various pharmaceutical companies, research organisations and healthcare equipment manufacturers. This has included ‘Cambridge Healthcare and Biotech’ on yet-to-be-marketed antibiotics.
In the past, has performed research sponsored by laboratory/sampling equipment manufacturers and the National Blood Service.
Previously an infection control doctor at the BUPA Cambridge Lea Hospital, lecturing regularly to BUPA nursing staff nationally on infection control.
Has received educational travel grants to attend scientific meetings in the UK and abroad throughout career, from various pharmaceutical companies.
Kate GouldSponsorship of travel to International Society of Heart and Lung Transplantation, and Interscience Conference on Antimicrobial Agents and Chemotherapy – Novartis.
Regional Microbiologist – HPA.
DIPC and Consultant Microbiologist – Newcastle upon Tyne Hospitals NHS Foundation Trust.
Sponsorship of travel to International Society for Heart and Lung Transplantation for other members of Laboratory team – Pfizer, Lederie, AstraZeneca.
David LeaperPart-time medical advisor to Renovo who are in phase III trials of anti-scarring agents. Was given a small number of shares in the company when they went PLC. In the past, have acted in a similar capacity to Arizant and Inditherm who make warming products. In addition, advise Hutchinson in the USA with regard to the development and evaluation of a new device to measure tissue oxygen. Also an invited and honorarium-paid lecturer with Smith and Nephew and Ethicon.
Clinical trials in conjunction with Ethicon, Hutchinson, and NitricBio. Trials involve sutures and wound care products.
Cardiff/Swansea group have financial support to undertake trial work.
New research group in Salisbury is in part funded by Convatec and financial support is pending from Ethicon, through a competitive grant from their Foundation, Tyco, Coloplast, Novartis and possibly Insense. Much of this work relates to topics in postoperative SSI care.
In the past, have had many charitable and industry grants for research work which is now complete. This has been in the area of antibiotic prophylaxis and treatment, dressings research and tissue perfusion. Pecuniary support from several companies has been provided to attend and give papers to international societies and for educational activities. Most was related to the Surgical Infection Society and the European Wound Management Association of which I have been President and the European Tissue Repair Society of which I am currently on the board.

From: Appendix A, Declarations of interest

Cover of Surgical Site Infection
Surgical Site Infection: Prevention and Treatment of Surgical Site Infection.
NICE Clinical Guidelines, No. 74.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2008 Oct.
Copyright © 2008, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.